4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-23-040748
Chief Accounting Officer sold 412 shares at $31.22 ($12,863)
- Chief Accounting Officer acquired 412 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lyon Joseph Douglas Chief Accounting Officer | 2023-08-07 | Sale 10b5-1 | −412 | $31.22 | $12,863 | 4,720 | D |
| Lyon Joseph Douglas Chief Accounting Officer | 2023-08-07 | Option exercise 10b5-1 | +412 | $8.27 | $3,407 | 5,132 | D |
| Derivatives | |||||||
| Lyon Joseph Douglas Chief Accounting Officer | 2023-08-07 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −412 | 51,571 | D | ||
| Open-market sales · 412 sh · avg $31.22 · $12,863 | |||||||
Loading xslF345X05/ownership.xml…